我院自1990年始，对无法手术切除的32例原发性肝癌及20例原发灶可切除的继发性肝癌行经肝动脉、门静脉双插管介入治疗。术后半年、一年、二年生存率分别为原发性肝癌40％、19％、6％：继发性肝癌95%、65%、20%。原发性肝癌肿瘤缩小＞50%为37%，25%～50%为34%，＜25%为28%：继发性肝癌分别为40%、25%、35%。部分患者AFP、CEA降至正常。结果表明双插管介人治疗对肝癌有一定疗效。 In our hospital since 1990, 32 cases of unresectable primary hepatocellular carcinoma and 20 cases of resectable secondary hepatocarcinoma of the primary lesion were treated with hepatic artery and portal vein double interventional therapy. The half-year, one-year, and two-year survival rates were 40%, 19%, and 6% of primary liver cancer, respectively: 95%, 65%, and 20% of secondary liver cancer. The tumor shrinkage in primary liver cancer was >30%, 37%, 25% to 50%, 34%, and <25%, 28%; secondary liver cancer was 40%, 25%, and 35%, respectively. Some patients AFP, CEA to normal. The results show that double intubation treatment has a certain effect on liver cancer.